Introduction
It has recently been suggested that there has been an increase in the incidence of neonatal jaundice, and that this might be due to an increase in the use of oxytocic drugs in the management of labour (Ghosh and Hudson, 1972) . Since oxytocin (Syntocinon) is often administered intravenously to induce or accelerate labour in our obstetric unit we have felt it mandatory to make a critical appraisal of this possible relation between the administration of oxytocin to the mother and the level of bilirubin in the neonate. This communication summarizes the results of a prospective study and indicates some possible lines for future research. Clinical material and methods Seventy-eight healthy, full-term infants were studied; haemolytic disease (Rhesus and ABO incompatibility) was excluded. They were divided into the following three groups depending on the pattern of the mother's labour: Group A-Spontaneous onset of labour, no oxytocic drugs (28 infants). Group B-Spontaneous onset of labour, oxytocin given to expedite labour (14 infants). Group C-Labour artificially induced by amniotomy followed immediately by intravenous oxytocin infusion (36 infants).
Capillary blood was obtained by heel prick on the second day from each infant and on the fifth day from those infants who were still in hospital. Total serum bilirubin was determined by a spectrophotometric method (White et al., 1958 
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The distribution in groups A, B, and C of birth weight, gestational age, breast-feeding, and operative delivery, all of which are known to influence the level of bilirubin in the neonate are shown in table II. Since the factors are similarly represented in all three groups they are unlikely to account for the higher total bilirubin levels found in infants of group C.
Investigations into possible causes of neonatal jaundice require details of drugs used not only during labour but also towards the end of the pregnancy. The main drugs which were given to the mothers in our study during labour and in the 24 hours before the onset of labour are summarized in table III.
From this it appears that in mothers whose labour had been artificially induced with oxytocin (group C), nitrazepam (Moga- don) and bupivacaine (Marcaine-used for epidural analgesia) are more highly represented when compared with the other two groups, whereas the remaining drugs are fairly evenly distributed among the three groups.
Discussion
Though the numbers of infants in the present study are small the findings imply that oxytocin administration may have been responsible for the higher bilirubin values found in infants born to women whose labour had been induced with oxytocin. It is interesting that the infants of mothers given oxytocin to expedite delivery after spontaneous onset of labour (group B) had a mean bilirubin level not differing significantly from that in infants of mothers not given oxytocin (group A). It seems possible that the effect of oxytocin may be dose dependent, for in group B the average maximum infusion rate was only 12-0 mU/min (range 2-32) while in group C it was 16-8 mU/min (range 1-5-32). Furthermore, the average duration of oxytocin infusion was less in group B (5 hr 45 min) compared with group C (7 hr 20 min). On the other hand this association between higher neonatal bilirubin levels with maternally administered oxytocin might be spurious. Perhaps the infants in group C are peculiarly susceptible to developing a greater degree of neonatal hyperbilirubinaemia. Pursuing this line of argument it may be that other drugs given to the mothers are involved and what is being observed is a cumulative drug effect. Nitrazepam and bupivacaine were used much more in the mothers of group C (table  III) and they may be responsible, though there are no preceding references in the literature to an association between these drugs and neonatal hyperbilirubinaemia. Detailed investigations of liver and red cell function will be required before the association between maternal oxytocin administration and neonatal hyperbilirubinaemia can be explained.
A third possibility takes into account the differences in corticosteroid status of the infant groups. Murphy (1973) has shown that at birth the umbilical cord serum cortisol levels are higher when labour has been of spontaneous onset than when induced, and these findings have recently been confirmed in Cardiff (Anderson et al., 1973) . Furthermore, this naturally occurring cortisol spurt towards the end of pregnancy might have an important role in the maturation of organ systems which are necessary for extrauterine survival (Murphy, 1973 ). An increasing number of liver enzymes are now known to be corticosteroid inducible (Rose and Braidman, 1970; Curzon, 1969) , and it might be expected that the hepatic enzymes necessary for the excretion of bilirubin are also of this category. Adrenocorticosteroids could then be seen to have an important function in preparing the fetal and neonatal liver to manage the early postnatal bilirubin load. If this were so, the association between matemal oxytocin infusion and -neonatal hyperbilirubinaemia would then be spurious, instead reflecting a level of relative hepatic enzyme immaturity in the offspring of women who do not spontaneously enter parturition.
It is important to view this association in perspective, however, particularly since oxytocin infusion is now such a common and invaluable agent in the management of labour in avoiding prolonged and difficult labour and operative delivery. An analogy with breast milk jaundice would seem reasonable. Breastfeeding is a well recognized causal factor in the production of neonatal jaundice (Arias et al., 1964 ) and a bilirubin level above 10 mg/100 ml is not infrequent in full term, breast-fed infants during the first week of life. It is unlikely that harm results from this degree of hyperbilirubinaemia and in clinical practice it is rarely a sufficient indication for discontinuing breast-feeding. In the present study there was nothing to suggest that any neurological damage would result from the infants' higher bilirubin levels in group C and during the whole study only two required treatment wih phototherapy, one each in group A and group C. Nevertheless, bilirubin neurotoxicity can no longer be regarded an "all or none" phenomenon. In fact, a wide spectrum of brain damage is recognized which can range from a mild disturbance in cognitive function to death from kernicteru s (Lucey, 1972) . The minimum bilirubin level at which such brain damage can develop in the full term infant remains unknown, and though it has been suggested that in the absence of hypoxia, hypothermia, acidosis, or a low serum albumin a bilirubin level of 20 mg/100 ml or less has no effect on subsequent I.Q. (British Medical Journal, 1972) , this is clearly not an area for complacency. Further work is required not only on the relation between maternal oxytocin infusion and neonatal jaundice but also on the finer details of bilirubin neurotoxicity in the long term.
